This Web conference focused on the role of the board of directors in formulating, evaluating and pursuing an acquisition or divestiture strategies in light of the unprecedented change in the financial markets. We also discussed how the credit crisis has affected the M&A market for buyers and sellers, some of the recent trends in deal terms, and the keys to successful transactions in today’s environment.
The panel was moderated by Foley Partners Steven H. Hilfinger and Peter C. Underwood and included panelists: Robin Johnson, Corporate Finance and Commercial Partner, Eversheds, LLP, Will Frame, Managing Director, Deloitte & Touche Corporate Finance, LLC, and Walter J. (“Bud”) Aspatore, Chairman, Amherst Capital Partners LLC.
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.